Suppr超能文献

聚山梨酯 80 浓度对单克隆抗体热稳定性和光稳定性的影响。

Effect of polysorbate 80 concentration on thermal and photostability of a monoclonal antibody.

机构信息

Formulation Development department, ImClone Systems, A Wholly owned subsidiary of Eli Lilly and Company, 59/61 ImClone Drive, Branchburg, New Jersey 08876, USA.

出版信息

AAPS PharmSciTech. 2013 Mar;14(1):1-9. doi: 10.1208/s12249-012-9878-0. Epub 2012 Nov 14.

Abstract

Polysorbate 80 is widely used in protein formulations to protect protein against agitation-induced aggregation. In this study, we address concerns about residual peroxide present in Polysorbate 80 on protein stability. Residual peroxide may oxidize active pharmaceutical ingredients leading to reduced stability and may ultimately lead to lower potency and efficacy. The effect of Polysorbate 80 concentration on thermal and photostability of monoclonal antibody of the IgG1 subclass (MAb1) was evaluated at Polysorbate 80 concentrations ranging from 0.00% to 1.00% (w/v). MAb1 samples at 5 mg/mL with various Polysorbate 80 concentrations were subjected to accelerated thermal stress by incubation at 25°C, 40°C, and 50°C for a period of 4 weeks and light stress per ICH guideline Q1B, option 1. Our results show that Polysorbate 80 concentration of 1.00% (w/v) adversely affected thermal and photostability of MAb1. This study demonstrates the importance of carefully choosing Polysorbate 80 concentration in protein formulations to prevent destabilizing effect of Polysorbate 80 on thermal and photostability.

摘要

聚山梨酯 80 广泛用于蛋白质制剂中,以保护蛋白质免受搅拌诱导的聚集。在这项研究中,我们关注聚山梨酯 80 中存在的残留过氧化物对蛋白质稳定性的影响。残留的过氧化物可能会氧化活性药物成分,导致稳定性降低,最终可能导致效力和功效降低。在聚山梨酯 80 浓度为 0.00%至 1.00%(w/v)的范围内,评估了聚山梨酯 80 浓度对 IgG1 类单克隆抗体(MAb1)的热稳定性和光稳定性的影响。在 5mg/mL 的 MAb1 样品中加入不同浓度的聚山梨酯 80,在 25°C、40°C 和 50°C 下孵育 4 周,按照 ICH 指南 Q1B、选项 1 进行光稳定性测试。结果表明,1.00%(w/v)的聚山梨酯 80 浓度对 MAb1 的热稳定性和光稳定性有不利影响。本研究表明,在蛋白质制剂中仔细选择聚山梨酯 80 的浓度对于防止聚山梨酯 80 对热稳定性和光稳定性的破坏作用非常重要。

相似文献

8
Surface activity of a monoclonal antibody.单克隆抗体的表面活性。
J Pharm Sci. 2009 Dec;98(12):4525-33. doi: 10.1002/jps.21776.
9
Self-buffering antibody formulations.自缓冲抗体制剂
J Pharm Sci. 2008 Aug;97(8):3051-66. doi: 10.1002/jps.21232.

引用本文的文献

3
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
7
Storage stability of lysostaphin solution and its pulmonary delivery.溶葡萄球菌酶溶液的储存稳定性及其肺部递药。
Drug Deliv Transl Res. 2024 Sep;14(9):2433-2443. doi: 10.1007/s13346-024-01518-9. Epub 2024 Jan 17.
8
Oxidation of polysorbates - An underestimated degradation pathway?聚山梨酯的氧化——一种被低估的降解途径?
Int J Pharm X. 2023 Jul 27;6:100202. doi: 10.1016/j.ijpx.2023.100202. eCollection 2023 Dec 15.

本文引用的文献

3
Molecular origins of surfactant-mediated stabilization of protein drugs.表面活性剂介导的蛋白质药物稳定化的分子起源。
Adv Drug Deliv Rev. 2011 Oct;63(13):1160-71. doi: 10.1016/j.addr.2011.06.015. Epub 2011 Jul 6.
5
Stability of protein pharmaceuticals: an update.蛋白质类药物的稳定性:最新进展。
Pharm Res. 2010 Apr;27(4):544-75. doi: 10.1007/s11095-009-0045-6. Epub 2010 Feb 9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验